×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
MP06-08: Serum vitamin D levels in females with urinary incontinence: a meta-analysis of observational trials
2021-05-24
MP06-07: XX male syndrome : A rare cause of male infertility, case analysis in a tertiary fertility service
2021-05-24
MP06-06: Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse
2021-05-24
MP06-05: The video urodynamic characteristics in SCI patients with different injury level and bladder condition
2021-05-24
MP06-04: Urethra-sphincter complex volume predictive of residual diverticulum after diverticulectomy
2021-05-24
MP06-03: Routine use of prophylactic metoclopramide after transperitoneal robotic-assisted radical prostatectomy: really needed?
2021-05-24
MP06-02: The senhance robotic system is feasible in oncologic and non-oncologic urologic surgeries: initial experiences and troubleshooting of new system
2021-05-24
MP06-01: Impact of obesity on the outcome of prostate cancer post robot-assisted radical prostatectomy
2021-05-24
MP05-10: Results of bevacizumab plus erlotinib in patients with metastatic type 2 papillary renal cell cancer - experience in Taipei Veterans General Hospital
2021-05-24
MP05-09: Glutathione s-transferase Mu 5 plays anti-tumor activity in bladder cancer cells
2021-05-24
MP05-08: Anti-cancer effects and tumor marker role of glutathione s-transferase mu 5 in human bladder cancer
2021-05-24
MP05-07: Hyperthermia inhibits chemotherapeutic drug resistance of bladder cancer cells through epithelial mesenchymal transition down-regulation
2021-05-24
MP05-06: External validation of Likert scale for predicting non-muscle invasive bladder cancer, KCGMH experience
2021-05-24
MP05-05: Cadherin-11 regulates cell pyroptosis and induces anti-tumor immunity through PD-L1 in bladder cancer
2021-05-24
MP05-04: The attenuation of chloroquine and hydroxychloroquine on the invasive potential of bladder cancer by targeting MMP-2 expression
2021-05-24
MP05-03: Small non-coding microRNAs (miRNAs) target hepatoma-derived growth factor (HDGF) as a novel therapeutic strategy for urothelial carcinoma
2021-05-24
MP05-02: PR-619, an inhibitor of deubiquitylating enzymes, reverses drug resistance in cisplatin-resistant urothelial carcinoma cells via suppression of c-myc
2021-05-24
MP05-01: The prognostic impact of tumour architecture for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
2021-05-24
MP04-10: Strangulated urethral prolapse occurring in a patient being treated for central precocious puberty
2021-05-24
MP04-09: The role of PRP injection in the prophylaxis of recurrent UTI in women-any predictive factor?
2021-05-24
MP04-08: The effect of uric acid on the calcium oxalate crystallization
2021-05-24
MP04-07: Obesity-related indices and its association with kidney stone
2021-05-24
MP04-06: The association between phthalate levels in urine and urinary uric acid
2021-05-24
MP04-05: The alteration of urinary protein after SWL in the patients with nephrolithiasis
2021-05-24
<
41
42
43
44
45
46
47
48
49
50
>
/ 127